Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBBY
576
Bed Bath & Beyond
BBBY
$403M
| $24.6M | 0.04% |
831,380
+171,160
| +26% | +$3.16M |
|
|
MRSH
577
Marsh
MRSH
$90.1B
| $24.6M | 0.04% |
130,700
+5,299
| +4% | +$940K |
|
578
Hackett Group
HCKT
$278M
| $24.6M | 0.04% |
1,099,246
-8,100
| -0.7% | -$159K |
|
579
Cigna
CI
$73.3B
| $24.5M | 0.04% |
87,192
+30,333
| +53% | +$7.9M |
|
580
Kearny Financial
KRNY
$600M
| $24.5M | 0.04% |
3,468,683
-58,530
| -2% | -$434K |
|
581
Louisiana-Pacific
LPX
$5.15B
| $24.4M | 0.04% |
325,100
-105,800
| -25% | -$6.54M |
|
582
Canadian Natural Resources
CNQ
$98.1B
| $24.4M | 0.04% |
866,000
-100,600
| -10% | -$2.87M |
|
583
Ally Financial
ALLY
$13.5B
| $24.3M | 0.04% |
898,100
-1,584,800
| -64% | -$42.1M |
|
584
Ryman Hospitality Properties
RHP
$7.82B
| $24.2M | 0.03% |
260,441
+38,800
| +18% | +$3.58M |
|
585
Unitil
UTL
$984M
| $24.2M | 0.03% |
477,151
-2,600
| -0.5% | -$144K |
|
586
Simon Property Group
SPG
$71.4B
| $24.1M | 0.03% |
208,993
-227,305
| -52% | -$24.8M |
|
587
GitLab
GTLB
$6.89B
| $24.1M | 0.03% |
472,200
+121,800
| +35% | +$4.53M |
|
588
Trane Technologies
TT
$105B
| $24.1M | 0.03% |
126,068
+88,200
| +233% | +$15.7M |
|
589
LiveRamp
RAMP
$2.3B
| $24M | 0.03% |
839,178
+108,100
| +15% | +$2.68M |
|
590
Moderna
MRNA
$25.4B
| $23.9M | 0.03% |
196,699
-140,013
| -42% | -$18.7M |
|
591
Gaming and Leisure Properties
GLPI
$12.5B
| $23.9M | 0.03% |
492,930
+109,700
| +29% | +$5.47M |
|
592
Travere Therapeutics
TVTX
$5.86B
| $23.9M | 0.03% |
1,555,013
-589,809
| -27% | -$10.7M |
|
593
SLB Ltd
SLB
$78.1B
| $23.8M | 0.03% |
484,804
-233,894
| -33% | -$11.2M |
|
594
Texas Roadhouse
TXRH
$14.1B
| $23.8M | 0.03% |
212,000
+86,200
| +69% | +$9.48M |
|
595
Oscar Health
OSCR
$9.14B
| $23.8M | 0.03% |
2,950,100
+1,512,900
| +105% | +$11.2M |
|
596
Myers Industries
MYE
$1.23B
| $23.7M | 0.03% |
1,221,697
+15,700
| +1% | +$308K |
|
597
Qiagen
QGEN
$8.88B
| $23.7M | 0.03% |
496,998
-74,924
| -13% | -$3.61M |
|
598
CVR Energy
CVI
$3.52B
| $23.7M | 0.03% |
790,984
-513,200
| -39% | -$13.8M |
|
599
Royalty Pharma
RPRX
$26.4B
| $23.7M | 0.03% |
770,700
-530,200
| -41% | -$18M |
|
600
Apple Hospitality REIT
APLE
$3.71B
| $23.6M | 0.03% |
1,559,700
+188,400
| +14% | +$2.86M |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.